PGC-1β modulates statin-associated myotoxicity in mice.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
02 2019
Historique:
received: 27 07 2018
accepted: 29 11 2018
pubmed: 5 12 2018
medline: 19 5 2020
entrez: 5 12 2018
Statut: ppublish

Résumé

Statins inhibit cholesterol biosynthesis and lower serum LDL-cholesterol levels. Statins are generally well tolerated, but can be associated with potentially life-threatening myopathy of unknown mechanism. We have shown previously that statins impair PGC-1β expression in human and rat skeletal muscle, suggesting that PGC-1β may play a role in statin-induced myopathy. PGC-1β is a transcriptional co-regulator controlling the expression of important genes in mitochondrial biogenesis, antioxidative capacity and energy metabolism. The principle aim of the current study was to investigate the interaction between atorvastatin and PGC-1β in more detail. We therefore treated wild-type mice and mice with selective skeletal muscle knockout of PGC-1β (PGC-1β

Identifiants

pubmed: 30511338
doi: 10.1007/s00204-018-2369-7
pii: 10.1007/s00204-018-2369-7
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha 0
Ppargc1a protein, mouse 0
Atorvastatin A0JWA85V8F
Hydrogen Peroxide BBX060AN9V
Myosin Heavy Chains EC 3.6.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

487-504

Subventions

Organisme : Agence Nationale de la Recherche
ID : 05-PCOD-032
Pays : International
Organisme : Agence Nationale de la Recherche
ID : ANR-10-LABX-0030-INRT
Pays : International
Organisme : Agence Nationale de la Recherche
ID : ANR-10-IDEX-0002-02
Pays : International
Organisme : Agence Nationale de la Recherche
ID : 2010BLAN1108-01
Pays : International
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 31003A_156270
Pays : International

Auteurs

François Singh (F)

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital, Hebelstrasse 20, 4031, Basel, Switzerland.
Université de Strasbourg, Fédération de Médecine Translationnelle, Equipe d'Accueil 3072, Institut de Physiologie, Faculté de Médecine, Strasbourg, France.

Joffrey Zoll (J)

Université de Strasbourg, Fédération de Médecine Translationnelle, Equipe d'Accueil 3072, Institut de Physiologie, Faculté de Médecine, Strasbourg, France.

Urs Duthaler (U)

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital, Hebelstrasse 20, 4031, Basel, Switzerland.

Anne-Laure Charles (AL)

Université de Strasbourg, Fédération de Médecine Translationnelle, Equipe d'Accueil 3072, Institut de Physiologie, Faculté de Médecine, Strasbourg, France.

Miljenko V Panajatovic (MV)

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital, Hebelstrasse 20, 4031, Basel, Switzerland.
Université de Strasbourg, Fédération de Médecine Translationnelle, Equipe d'Accueil 3072, Institut de Physiologie, Faculté de Médecine, Strasbourg, France.

Gilles Laverny (G)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique UMR7104, Institut National de la Santé et de la Recherche Médicale, Illkirch, France.

Thomas G McWilliams (TG)

Research Programs Unit, Molecular Neurology, Faculty of Medicine, University of Helsinki, 00290, Helsinki, Finland.

Daniel Metzger (D)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique UMR7104, Institut National de la Santé et de la Recherche Médicale, Illkirch, France.

Bernard Geny (B)

Université de Strasbourg, Fédération de Médecine Translationnelle, Equipe d'Accueil 3072, Institut de Physiologie, Faculté de Médecine, Strasbourg, France.

Stephan Krähenbühl (S)

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital, Hebelstrasse 20, 4031, Basel, Switzerland.
Swiss Centre for Applied Human Research (SCAHT), Basel, Switzerland.

Jamal Bouitbir (J)

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital, Hebelstrasse 20, 4031, Basel, Switzerland. jamal.bouitbir@unibas.ch.
Swiss Centre for Applied Human Research (SCAHT), Basel, Switzerland. jamal.bouitbir@unibas.ch.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH